Table 1.
Baseline clinical characteristics.
Table 2.
The prevalence of anti-PLA2R Abs evaluated by ELISA and CIIFA in MN patients.
Fig 1.
Correlation between serum albumin levels and serum anti-PLA2R Ab levels measured by ELISA.
Table 3.
Clinical characteristics of the anti-PLA2R Ab-positive and -negative IMN patients.
Table 4.
Histopathological characteristics of the anti-PLA2R Ab-positive and -negative IMN patients.
Table 5.
The prevalence of glomerular PLA2R Ag expression in MN patients.
Table 6.
Comparison of the prevalence of serum anti-PLA2R Abs with glomerular PLA2R Ag expression in IMN patients.